EJC Supplements
Volume 5, Issue 5 , Pages 15-22, September 2007

The 7th Edition of the TNM Classification for Lung Cancer: Proposals from the IASLC Staging Project

Department of Thoracic Surgery, Royal Brompton Hospital, London, UK

Article Outline

Abstract 

The purpose of this presentation is three-fold: (a) to inform the lung cancer community of the proposals submitted by the International Association for the Study of Lung Cancer (IASLC) to the International Union Against Cancer (UICC) and the American Joint Committee on Cancer (AJCC) for the Lung Cancer section of the forthcoming (7th) Edition of the TNM Classification of Malignant Tumours, (b) to stimulate discussion within the lung cancer community ahead of these revisions being enacted, and (c) to describe to the wider oncological community the IASLC Lung Cancer Staging Project in the hope that it might provide a useful template by which revisions to the TNM Classification for other tumours could be better informed. This last issue will entail a description of the development of TNM staging in lung cancer, which, inevitably will be somewhat critical of the pre-existing process for revision. The UICC has sought to improve this and the previous speaker will address their process for change initiative. However, the relevant specialist associations and National groups can help to inform such revisions by stimulating collaborative, international efforts for data collection.

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Denoix PF. The TNM staging system. Bull Inst Nat Hyg (Paris). 1952;7:743
  2. UICC . TNM classification of malignant tumours. 1st.. Geneva: UICC; 1968;
  3. Mountain CF, Carr DT, Anderson WAD. A system for the clinical staging of lung cancer. Am J Roentogenol Rad Ther Nucl Med. 1974;120:130–138
  4. UICC . TNM classification of malignant tumours. 2nd.. Geneva: UICC; 1975;
  5. UICC . TNM classification of malignant tumours. 3rd.. Geneva: UICC; 1978;
  6. Mountain CF. A new international staging system for lung cancer. Chest. 1986;89S:225S–232S
  7. Hermanek P, Sobin LH, UICC . TNM classification of malignant tumours. 4th.. Berlin: Springer Verlag; 1987;
  8. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–1717
  9. UICC International Union Against Cancer . TNM classification of malignant tumours. In:  Sobin LH,  Wittekind C editor. 5th.. New York: Wiley-Liss; 1997;
  10. UICC International Union Against Cancer . TNM classification of malignant tumours. 6th ed.. New York: Wiley-Liss; 2002;
  11. Green FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th edition. New York: Springer-Verlag; 2002;
  12. Goldstraw P. Report on the International workshop on intrathoracic staging. London, October 1996. Lung Cancer. 1997;18:107–111
  13. Goldstraw P, Crowley JJ, IASLC International Staging Project . The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer. J Thorac Oncol. 2006;1:281–286
  14. Rami-Porta R, Ball D, Crowley JJ, et al, IASLC International Staging Project. The IASLC Lung Cancer Staging Project: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol [In press].
  15. Rusch VR, Crowley JJ, Goldstraw P, et al, IASLC International Staging Project. The IASLC Lung Cancer Staging Project: Proposals for revision of the N descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol [In press].
  16. Postmus PE, Brambilla E, Chansky K, et al, IASLC International Staging Project. The IASLC Lung Cancer Staging Project: Proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol [In press].
  17. Groome PA, Bolejack V, Crowley JJ, et al, IASLC International Staging Project. The IASLC Lung Cancer Staging Project: Validation of the proposals for revision of the T, N and M descriptors and consequent stage groupings in the forthcoming (seventh) TNM classification for lung cancer. J Thorac Oncol [In press]
  18. Goldstraw P, Chansky K, Crowley JJ, et al, IASLC International Staging Project. The IASLC Lung Cancer Staging Project: Proposals for revision of the stage groupings in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol [In press].
  19. Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer And Leukemia Group B (CALGB) protocol9633. Journal of Clinical Oncology. 2006;24:18s;[Abstract 7007]
  20. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients. Journal of Clinical Oncology. 2006;24:18s;[Abstract 2008]
  21. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer. New England Journal of Medicine. 2005;352:2589–2597
  22. Douillard JY, Rosell R, Delena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialists Association [ANITA]): A randomised controlled trial. Lancet oncology. 2006;17:719–727

PII: S1359-6349(07)70018-6

doi:10.1016/S1359-6349(07)70018-6

EJC Supplements
Volume 5, Issue 5 , Pages 15-22, September 2007